Release Date: 22/10/20 08:44 Summary: Sep20 Quarterly Activities update and Appendix 4C Price Sensitive: Yes Download Document 439.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%